For adults with active ankylosing spondylitis
The first and only treatment to offer both self-injection and IV infusion dosing options that target IL-17A.*
Want to learn more about taking COSENTYX?
*For adults.
Results fast. Relief that can last.†
COSENTYX is proven to help reduce symptoms of ankylosing spondylitis (AS).
16 WEEKS, 5 YEARS, #1 PRESCRIBED:
In as little as 16 weeks, twice as many people treated with COSENTYX achieved at least a 20% improvement in overall symptoms versus those taking placebo (61% vs 28%).
A similar percentage of people saw an improvement at 5 years as well.‡
COSENTYX is the #1 prescribed§ biologic treatment of its kind.¶
†All results shown from clinical trials using subcutaneous (under the skin) injection. The FDA approval of the intravenous (IV) administration (injected into a vein) of COSENTYX is based on data showing that the amount of the medication in your body after it is given directly through IV was within the range that would be seen when given as SC.
‡In this study, patients and doctors were told which medication was being used after 4 months. When patients and doctors know the study drug being used, it may affect the results.
§Across all indications.
¶Treatment for AS that targets IL-17A, one of the multiple molecules in the body that may play a role in inflammation.
How does COSENTYX work?
COSENTYX is the first biologic treatment of its kind to treat ankylosing spondylitis (AS) by specifically targeting and blocking IL-17A, one of the multiple molecules that is believed to play a role in causing inflammation. It’s the first and only treatment to offer both self-injection and IV infusion dosing options that target IL-17A.#
#As of January 2024.
Mark was moving and feeling better after a few months taking COSENTYX. Five years later, he’s still feeling relief from his ankylosing spondylitis symptoms. See what he’d tell others about getting started.
For more real stories from real people with AS, click here.